Is Nephros Stock a Good Investment?
Nephros Investment Advice | NEPH |
- Examine Nephros' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Nephros' leadership team and their track record. Good management can help Nephros navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Household Appliances space and any emerging trends that could impact Nephros' business and its evolving consumer preferences.
- Compare Nephros' performance and market position to its competitors. Analyze how Nephros is positioned in terms of product offerings, innovation, and market share.
- Check if Nephros pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Nephros' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Nephros stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Nephros is a good investment.
Sell | Buy |
Strong Hold
Market Performance | OK | Details | |
Volatility | Unstable | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Nephros Stock
Researching Nephros' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 13.0% of the company outstanding shares are owned by corporate insiders. The book value of Nephros was now reported as 0.79. The company recorded a loss per share of 0.09. Nephros last dividend was issued on the 10th of July 2019. The entity had 1:9 split on the 10th of July 2019.
To determine if Nephros is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Nephros' research are outlined below:
| Nephros may become a speculative penny stock | |
| Nephros has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 14.24 M. Net Loss for the year was (1.57 M) with profit before overhead, payroll, taxes, and interest of 8.31 M. | |
| Nephros has a poor financial position based on the latest SEC disclosures | |
| About 13.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from finance.yahoo.com: Analysts Expect Nephros, Inc. To Breakeven Soon |
Nephros Quarterly Cash And Short Term Investments |
|
Nephros uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Nephros. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Nephros' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 13th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Earnings surprises can significantly impact Nephros' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Nephros' investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-08-09 | 2023-06-30 | -0.05 | -0.04 | 0.01 | 20 | ||
2023-05-10 | 2023-03-31 | -0.02 | -0.03 | -0.01 | 50 | ||
2024-08-08 | 2024-06-30 | -0.01 | -0.03 | -0.02 | 200 | ||
2024-05-09 | 2024-03-31 | -0.04 | -0.02 | 0.02 | 50 | ||
2021-11-04 | 2021-09-30 | -0.1 | -0.12 | -0.02 | 20 | ||
2020-11-05 | 2020-09-30 | -0.14 | -0.12 | 0.02 | 14 | ||
2022-08-10 | 2022-06-30 | -0.15 | -0.12 | 0.03 | 20 | ||
2021-03-01 | 2020-12-31 | -0.11 | -0.08 | 0.03 | 27 |
Know Nephros' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Nephros is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Nephros backward and forwards among themselves. Nephros' institutional investor refers to the entity that pools money to purchase Nephros' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Mesirow Fin Investmt Mgmt Intl Equity | 2024-09-30 | 13.8 K | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 5.4 K | Tower Research Capital Llc | 2024-09-30 | 2.8 K | Jpmorgan Chase & Co | 2024-09-30 | 221 | Ubs Group Ag | 2024-09-30 | 121 | Bank Of America Corp | 2024-09-30 | 96.0 | Granite Investment Partners, Llc | 2024-09-30 | 0.0 | Wells Fargo & Co | 2024-06-30 | 0.0 | Goss Wealth Management Llc | 2024-06-30 | 0.0 | Wexford Capital Lp | 2024-09-30 | 3.6 M | Vanguard Group Inc | 2024-09-30 | 202 K |
Nephros' market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 17.61 M.Market Cap |
|
Nephros' profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.15) | (0.14) | |
| Return On Capital Employed | (0.16) | (0.15) | |
| Return On Assets | (0.12) | (0.13) | |
| Return On Equity | (0.22) | (0.23) |
Determining Nephros' profitability involves analyzing its financial statements and using various financial metrics to determine if Nephros is a good buy. For example, gross profit margin measures Nephros' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Nephros' profitability and make more informed investment decisions.
Evaluate Nephros' management efficiency
Nephros has return on total asset (ROA) of (0.0796) % which means that it has lost $0.0796 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1561) %, meaning that it created substantial loss on money invested by shareholders. Nephros' management efficiency ratios could be used to measure how well Nephros manages its routine affairs as well as how well it operates its assets and liabilities. The Nephros' current Return On Tangible Assets is estimated to increase to -0.14. The Nephros' current Return On Capital Employed is estimated to increase to -0.15. As of now, Nephros' Debt To Assets are decreasing as compared to previous years. The Nephros' current Asset Turnover is estimated to increase to 1.13, while Total Assets are projected to decrease to under 7.5 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.72 | 0.76 | |
| Tangible Book Value Per Share | 0.60 | 0.63 | |
| Enterprise Value Over EBITDA | (28.32) | (26.90) | |
| Price Book Value Ratio | 3.87 | 3.48 | |
| Enterprise Value Multiple | (28.32) | (26.90) | |
| Price Fair Value | 3.87 | 3.48 | |
| Enterprise Value | 30.1 M | 18.9 M |
Effective leadership at Nephros drives its competitive edge in the market. Our analysis focuses on how this translates to financial performance and stock value.
Beta 1.193 |
Basic technical analysis of Nephros Stock
As of the 31st of January, Nephros secures the Mean Deviation of 1.96, downside deviation of 2.6, and Risk Adjusted Performance of 0.1202. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Nephros, as well as the relationship between them.Nephros' insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Nephros insiders, such as employees or executives, is commonly permitted as long as it does not rely on Nephros' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Nephros insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Nephros' Outstanding Corporate Bonds
Nephros issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Nephros uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Nephros bonds can be classified according to their maturity, which is the date when Nephros has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| NLSN 929 15 APR 29 Corp BondUS640695AA01 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Understand Nephros' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Nephros' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.1202 | |||
| Market Risk Adjusted Performance | 0.3624 | |||
| Mean Deviation | 1.96 | |||
| Semi Deviation | 2.21 | |||
| Downside Deviation | 2.6 | |||
| Coefficient Of Variation | 735.96 | |||
| Standard Deviation | 2.52 | |||
| Variance | 6.36 | |||
| Information Ratio | 0.0963 | |||
| Jensen Alpha | 0.2479 | |||
| Total Risk Alpha | 0.0612 | |||
| Sortino Ratio | 0.0935 | |||
| Treynor Ratio | 0.3524 | |||
| Maximum Drawdown | 11.29 | |||
| Value At Risk | (3.21) | |||
| Potential Upside | 5.48 | |||
| Downside Variance | 6.75 | |||
| Semi Variance | 4.88 | |||
| Expected Short fall | (2.24) | |||
| Skewness | 0.1249 | |||
| Kurtosis | 0.1574 |
| Risk Adjusted Performance | 0.1202 | |||
| Market Risk Adjusted Performance | 0.3624 | |||
| Mean Deviation | 1.96 | |||
| Semi Deviation | 2.21 | |||
| Downside Deviation | 2.6 | |||
| Coefficient Of Variation | 735.96 | |||
| Standard Deviation | 2.52 | |||
| Variance | 6.36 | |||
| Information Ratio | 0.0963 | |||
| Jensen Alpha | 0.2479 | |||
| Total Risk Alpha | 0.0612 | |||
| Sortino Ratio | 0.0935 | |||
| Treynor Ratio | 0.3524 | |||
| Maximum Drawdown | 11.29 | |||
| Value At Risk | (3.21) | |||
| Potential Upside | 5.48 | |||
| Downside Variance | 6.75 | |||
| Semi Variance | 4.88 | |||
| Expected Short fall | (2.24) | |||
| Skewness | 0.1249 | |||
| Kurtosis | 0.1574 |
Consider Nephros' intraday indicators
Nephros intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Nephros stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 1181.45 | |||
| Daily Balance Of Power | (0.30) | |||
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 1.67 | |||
| Day Typical Price | 1.67 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.03) |
Nephros Stock media impact
Far too much social signal, news, headlines, and media speculation about Nephros that are available to investors today. That information is available publicly through Nephros media outlets and privately through word of mouth or via Nephros internal channels. However, regardless of the origin, that massive amount of Nephros data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Nephros news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Nephros relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Nephros' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Nephros alpha.
Nephros Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Nephros can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Nephros Corporate Management
| Vashone Thomas | Regulatory, Quality | Profile | |
| Joleen Turner | VP Devel | Profile | |
| Judy CFA | Chief Officer | Profile | |
| Judy Mazzini | Controller | Profile | |
| MS MBA | Inc Products | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nephros. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in Nephros Stock please use our How to Invest in Nephros guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Household Appliances space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nephros. If investors know Nephros will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nephros listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.09) | Revenue Per Share | Quarterly Revenue Growth (0.08) | Return On Assets | Return On Equity |
The market value of Nephros is measured differently than its book value, which is the value of Nephros that is recorded on the company's balance sheet. Investors also form their own opinion of Nephros' value that differs from its market value or its book value, called intrinsic value, which is Nephros' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nephros' market value can be influenced by many factors that don't directly affect Nephros' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Nephros' value and its price, as these two are different measures arrived at by various means. Investors typically determine if Nephros is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nephros' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.